Marcaine Spinaal

Bupivacaine hydrochloride, the active ingredient in Marcaine Spinaal, is a local anesthetic presented as a sterile solution for intrathecal and infiltration use. It provides profound sensory blockade for surgical procedures, regional nerve blocks and spinal anesthesia in adult patients.

GNH USA supplies Marcaine Spinaal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Marcaine Spinaal is a local anesthetic used in various anesthesia techniques to achieve reversible loss of sensation.

- Surgical anesthesia: enables complete analgesia for operative procedures requiring general or regional techniques. - Regional nerve block: provides targeted numbness for limb or trunk surgeries. - Epidural and spinal anesthesia: produces reliable sensory block for obstetric, urologic and orthopedic interventions.

Marcaine Spinaal may be associated with a range of adverse reactions following administration.

Common Side Effects: - Hypotension: transient drop in blood pressure. - Bradycardia: slowed heart rate. - Nausea: mild to moderate upset stomach. - Dizziness: feeling of light‑headedness. - Pruritus: localized itching at injection site. - Headache: mild post‑procedural headache.

Serious or Rare Side Effects: - Cardiac arrhythmia: abnormal heart rhythm. - Central nervous system toxicity: seizures or altered mental status. - Respiratory depression: reduced breathing effort. - Allergic reaction: rash, swelling or anaphylaxis. - Persistent neurologic deficit: prolonged numbness or weakness. - Spinal hematoma: bleeding in the spinal canal.

When using Marcaine Spinaal, clinicians should observe specific safety measures.

- Patient assessment: evaluate cardiovascular and neurologic status before administration. - Dose limitation: avoid exceeding recommended maximum dose for the specific route. - Monitoring: continuously observe vital signs and level of block during the procedure. - Contraindications: do not use in patients with known hypersensitivity to amide‑type local anesthetics. - Drug interactions: review concomitant medications that may affect cardiac conduction. - Storage: Store at 2‑8 °C: keep refrigerated, protect from light, do not freeze or shake.

Marcaine Spinaal can interact with other agents that influence cardiac or neurologic function.

Major Interactions (Avoid): - Class I anti‑arrhythmics (e.g., quinidine, procainamide): may potentiate cardiotoxicity. - Beta‑blockers: increase risk of severe bradycardia. - Central nervous system depressants (e.g., opioids, benzodiazepines): may enhance respiratory depression.

Moderate Interactions (Monitor Closely): - Calcium channel blockers: may affect cardiac conduction. - MAO inhibitors: potential for enhanced local anesthetic toxicity. - Diuretics: may alter plasma protein binding, affecting drug levels.